JPS53130437A - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
JPS53130437A
JPS53130437A JP4621578A JP4621578A JPS53130437A JP S53130437 A JPS53130437 A JP S53130437A JP 4621578 A JP4621578 A JP 4621578A JP 4621578 A JP4621578 A JP 4621578A JP S53130437 A JPS53130437 A JP S53130437A
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP4621578A
Other languages
Japanese (ja)
Inventor
Alfred G Maasboel
Alexander K Sim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Karl O Helm AG
Original Assignee
Karl O Helm AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2717062A external-priority patent/DE2717062C2/en
Priority claimed from DE2717001A external-priority patent/DE2717001C2/en
Application filed by Karl O Helm AG filed Critical Karl O Helm AG
Publication of JPS53130437A publication Critical patent/JPS53130437A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235Saturated compounds containing more than one carboxyl group
    • C07C59/245Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/255Tartaric acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18Aralkyl radicals
    • C07D217/20Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • C07D221/18Ring systems of four or more rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/04Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/22Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
    • C07C2603/26Phenanthrenes; Hydrogenated phenanthrenes
JP4621578A 1977-04-18 1978-04-18 Pharmaceutical composition Pending JPS53130437A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2717062A DE2717062C2 (en) 1977-04-18 1977-04-18 Medicines with an antitussive effect
DE2717001A DE2717001C2 (en) 1977-04-18 1977-04-18 Medicines with an antithrombotic effect

Publications (1)

Publication Number Publication Date
JPS53130437A true JPS53130437A (en) 1978-11-14

Family

ID=25771874

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4621578A Pending JPS53130437A (en) 1977-04-18 1978-04-18 Pharmaceutical composition

Country Status (7)

Country Link
JP (1) JPS53130437A (en)
AU (1) AU520608B2 (en)
CA (1) CA1098035A (en)
FR (1) FR2387652A1 (en)
GB (1) GB1587378A (en)
IT (1) IT1104846B (en)
NL (1) NL7803601A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5645459A (en) * 1979-09-20 1981-04-25 Otsuka Pharmaceut Co Ltd Cyclic amine
JP2005537332A (en) * 2002-08-30 2005-12-08 セダーマ エス.アー.エス. New noraporphine derivatives

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5645459A (en) * 1979-09-20 1981-04-25 Otsuka Pharmaceut Co Ltd Cyclic amine
JPH0144711B2 (en) * 1979-09-20 1989-09-29 Otsuka Pharma Co Ltd
JP2005537332A (en) * 2002-08-30 2005-12-08 セダーマ エス.アー.エス. New noraporphine derivatives

Also Published As

Publication number Publication date
FR2387652A1 (en) 1978-11-17
GB1587378A (en) 1981-04-01
CA1098035A (en) 1981-03-24
IT7848932A0 (en) 1978-04-17
IT1104846B (en) 1985-10-28
AU520608B2 (en) 1982-02-11
NL7803601A (en) 1978-10-20
FR2387652B1 (en) 1982-04-23
AU3519878A (en) 1979-10-25

Similar Documents

Publication Publication Date Title
JPS53113007A (en) Pharmaceutical composition
JPS53109934A (en) Pharmaceutical composition
ZA785682B (en) Pharmaceutical compositions
GB2003028B (en) Pharmaceutical compositions
JPS5484022A (en) Pharmaceutical composition
JPS5449333A (en) Pharmaceutical composition
JPS53133637A (en) Pharmaceutical composition
PH15193A (en) Pharmaceutical composition
GB2021409B (en) Pharmaceutical composition
GB2002229B (en) Pharmaceutical composition
GB2008403B (en) Pharmaceutical compositions
JPS5394038A (en) Pharmaceutical composition
JPS5486607A (en) Solid pharmaceutical composition
ZA78671B (en) Pharmaceutical compositions
ZA784470B (en) Pharmaceutical compositions including antithormbotic compositions
NZ186334A (en) Oxadiazolopyrimidines:pharmaceutical compositions
IL54220A0 (en) Pharmaceutical compositions comprising trans-broparestrol
JPS53101520A (en) Pharmaceutical composition
GB2008408B (en) Pharmaceutical compositions
ZA7812B (en) Pharmaceutical compositions
JPS545045A (en) Pharmaceutical composition
ZA782736B (en) Pharmaceutical compositions
GB1556851A (en) Pharmaceutical compositions
JPS542338A (en) Pharmaceutical composition
JPS5480427A (en) Pharmaceutical composition having antiiviral property